Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Aug;41(4):396–402. doi: 10.1136/ard.41.4.396

Studies on autoantibodies to poly (adenosine diphosphate-ribose) in SLE and other autoimmune diseases.

W J Morrow, D A Isenberg, H F Parry, L Shen, E E Okolie, F Farzaneh, S Shall, M L Snaith
PMCID: PMC1000957  PMID: 6981386

Abstract

Sera from 41 patients with systemic lupus erythematosus (SLE), 87 controls with various diseases, and 30 normal subjects were examined for poly (adenosine diphosphate-ribose) and ds DNA binding. Elevated levels of poly (ADP-ribose) binding were found in 73% of the SLE patients compared with 58% who had raised ds DNA binding. In a further study of 160 sera from 27 patients with SLE, levels of antipoly (ADP-ribose) antibodies were shown to correlate with clinical activity better than either anti-ds DNA or ss DNA antibodies.

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arden L. A., Lakmaker F., Feltkamp T. E. Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay. J Immunol Methods. 1976;10(1):39–48. doi: 10.1016/0022-1759(76)90005-3. [DOI] [PubMed] [Google Scholar]
  2. BLOCH K. J., BUCHANAN W. W., WOHL M. J., BUNIM J. J. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965 May;44:187–231. [PubMed] [Google Scholar]
  3. Cameron J. S., Lessof M. H., Ogg C. S., Williams B. D., Williams D. G. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol. 1976 Sep;25(3):418–427. [PMC free article] [PubMed] [Google Scholar]
  4. Davis P., Percy J. S., Russell A. S. Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis. 1977 Apr;36(2):157–159. doi: 10.1136/ard.36.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis P., Russell A. S., Percy J. S. A comparative study of technics for the detection of antibodies to native deoxyribonucleic acid. Am J Clin Pathol. 1977 Apr;67(4):374–378. doi: 10.1093/ajcp/67.4.374. [DOI] [PubMed] [Google Scholar]
  6. Edmonds J. P., Johnson G. D., Ansell B. M., Holborow E. J. The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic method. Clin Exp Immunol. 1975 Oct;22(1):9–15. [PMC free article] [PubMed] [Google Scholar]
  7. Eilat D., Steinberg A. D., Schechter A. N. The reaction of SLE antibodies with native, single stranded RNA: radioassay and binding specificities. J Immunol. 1978 Feb;120(2):550–557. [PubMed] [Google Scholar]
  8. FARR R. S. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis. 1958 Nov-Dec;103(3):239–262. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
  9. Hayaishi O., Ueda K. Poly(ADP-ribose) and ADP-ribosylation of proteins. Annu Rev Biochem. 1977;46:95–116. doi: 10.1146/annurev.bi.46.070177.000523. [DOI] [PubMed] [Google Scholar]
  10. Holian J., Griffiths I. D., Glass D. N., Maini R. N., Scott J. T. Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 1975 Oct;34(5):438–443. doi: 10.1136/ard.34.5.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jain S., Markham R., Thomas H. C., Sherlock S. Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol. 1976 Oct;26(1):35–41. [PMC free article] [PubMed] [Google Scholar]
  12. Kanai Y., Kawaminami Y., Miwa M., Matsushima T., Sugimura T. Naturally-occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus. Nature. 1977 Jan 13;265(5590):175–177. doi: 10.1038/265175a0. [DOI] [PubMed] [Google Scholar]
  13. Koffler D., Carr R., Agnello V., Thoburn R., Kunkel H. G. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med. 1971 Jul 1;134(1):294–312. doi: 10.1084/jem.134.1.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lange A. Evaluation of the simultaneous estimation of anti-dsDNA and anti-ssDNA antibodies for clinical purposes. Clin Exp Immunol. 1978 Mar;31(3):472–481. [PMC free article] [PubMed] [Google Scholar]
  15. Okolie E. E., Shall S. The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus. Clin Exp Immunol. 1979 Apr;36(1):151–164. [PMC free article] [PubMed] [Google Scholar]
  16. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  17. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  18. ROTHFIELD N. F., PACE N. Relation of positive L.E.-cell preparations to activity of lupus erythematosus and corticosteroid therapy. N Engl J Med. 1962 Mar 15;266:535–538. doi: 10.1056/NEJM196203152661103. [DOI] [PubMed] [Google Scholar]
  19. Schur P. H., Monroe M. Antibodies to ribonucleic acid in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1108–1112. doi: 10.1073/pnas.63.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schur P. H., Stollar B. D., Steinberg A. D., Talal N. Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. Arthritis Rheum. 1971 May-Jun;14(3):342–347. doi: 10.1002/art.1780140304. [DOI] [PubMed] [Google Scholar]
  21. Sherlock S. Chronic hepatitis. Gut. 1974 Jul;15(7):581–597. doi: 10.1136/gut.15.7.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Steinberg A. D., Baron S., Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1102–1107. doi: 10.1073/pnas.63.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Talal N., Steinberg A. D., Daley G. G. Inhibition of antigodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids. J Clin Invest. 1971 Jun;50(6):1248–1252. doi: 10.1172/JCI106602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zein N., Ganuza C., Kushner I. Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis Rheum. 1979 Jan;22(1):7–12. doi: 10.1002/art.1780220102. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES